Biblio Discovery — Demo Discovery Service

10 hasil untuk "Pascal Pugliese"

Menampilkan 1–10 · 0,20 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice

    Pierre Gantner; Firouze Bani-Sadr; Rodolphe Garraffo dkk.

    PLOS ONE, Vol. 11 No. 10 · 2016 · Inggris · PLOS Scopus

    Objectives: To assess immunovirological response, safety and pharmacokinetic of NRTI-sparing regimen dual therapy of atazanavir (ATV) and raltegravir (RAL) in maintenance strategy. Methods: A retrospective analysis was conducted on a cohort of HIV-infected adults followed in French centers…

  2. Artikel Jurnal Teks lengkap

    High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort

    Thomas Lemmet; Laurent Cotte; Clotilde Allavena dkk.

    PLOS ONE, Vol. 17 No. 5 · 2022 · Inggris · PLOS Scopus

    Background: In the past years, we observed a sharp increase of Syphilis, especially among male who have sex with male (MSM), either HIV-infected, or on pre-exposure prophylaxis (PrEP). Our aim was to assess syphilis prevalence and incidence among people living with HIV (PLWH) and PrEP users…

  3. Artikel Jurnal Teks lengkap

    Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score

    Maxime Hentzien; Cyrille Delpierre; Pascal Pugliese dkk.

    PLOS ONE, Vol. 13 No. 4 · 2018 · Inggris · PLOS Scopus

    Objective: The objective was to develop a multivariable prognostic index for overall mortality over a five-year span integrating classical HIV biomarkers and comorbidities in people living with HIV (PLHIV) aged 60 or older. Design: Prospective multicenter cohort study from the French Dat’AIDS…

  4. Artikel Jurnal Teks lengkap

    Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study

    Lise Cuzin; Pascal Pugliese; Clotilde Allavena dkk.

    PLOS ONE, Vol. 12 No. 12 · 2017 · Inggris · PLOS Scopus

    Objective: We investigated whether patients receiving selected antiretroviral combinations had a higher risk of chronic kidney disease (CKD) using traditional regression modeling and a causal approach in a large prospective cohort. Patients and methods: For the purpose of this study, we selected…

  5. Artikel Jurnal Teks lengkap

    Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

    Isabelle Poizot-Martin; Alissa Naqvi; Véronique Obry-Roguet dkk.

    PLOS ONE, Vol. 10 No. 10 · 2015 · Inggris · PLOS Scopus

    Objectives: Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral treatment (cART) is a real challenge in HIV/HCV coinfected patients. The aim of this study was to describe potential drug-drug…

  6. Artikel Jurnal Teks lengkap

    Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study

    Laurent Cotte; Tristan Ferry; Pascal Pugliese dkk.

    PLOS ONE, Vol. 12 No. 2 · 2017 · Inggris · PLOS Scopus

    Objectives: Pill burden during antiretroviral treatment (ART) is associated with worse adherence and impaired virological suppression. We compared the effectiveness, tolerance, and persistence on treatment of single tablet regimens (STRs) with non-STR once-daily regimens in patients receiving…

  7. Artikel Jurnal Teks lengkap

    Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection

    Pierre Gantner; Laurent Cotte; Clotilde Allavena dkk.

    PLOS ONE, Vol. 14 No. 4 · 2019 · Inggris · PLOS Scopus

    Introduction: Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare event. In this setting, factors related to HBV…

  8. Artikel Jurnal Teks lengkap

    Facilitating the access to HIV testing at lower costs: “To the laboratory without prescription” (ALSO), a pilot intervention to expand HIV testing through medical laboratories in France

    Karen Champenois; Victoire Sawras; Pamela Ngoh dkk.

    PLOS ONE, Vol. 19 No. 10 · 2024 · Inggris · PLOS Scopus

    Background: A pilot HIV testing programme, Au Labo sans Ordo (ALSO; “to the laboratory without prescription”) was implemented in two French Fast-Track Cities Initiative areas from 07/2019 to 12/2020. ALSO aimed to remove barriers to HIV testing by providing free testing with widespread access…

  9. Artikel Jurnal Teks lengkap

    Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients

    Clotilde Allavena; Matthieu Hanf; David Rey dkk.

    PLOS ONE, Vol. 13 No. 9 · 2018 · Inggris · PLOS Scopus

    As HIV-infected adults on successful antiretroviral therapy (ART) are expected to have close to normal lifespans, they will increasingly develop age-related comorbidities. The objective of this cross-sectional study was to compare in the French Dat’AIDS cohort, the HIV geriatric population, aged 75…

  10. Artikel Jurnal Teks lengkap

    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France

    Teresa Rojas Rojas; Isabelle Poizot-Martin; David Rey dkk.

    PLOS ONE, Vol. 17 No. 3 · 2022 · Inggris · PLOS Scopus

    Background: We aimed to evaluate the incidence rates between 2010 and 2015 for invasive cervical cancer (ICC), breast cancer (BC), and colorectal cancer (CRC) in people living with HIV (PLWH) in France, and to compare them with those in the French general population. These cancers are targeted by…